These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32594289)

  • 1. miR-128-3p enhances the protective effect of dexmedetomidine on acute lung injury in septic mice by targeted inhibition of MAPK14.
    Ding L; Gao X; Yu S; Sheng L
    J Bioenerg Biomembr; 2020 Aug; 52(4):237-245. PubMed ID: 32594289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA XIST knockdown alleviates LPS-induced acute lung injury by inactivation of XIST/miR-132-3p/MAPK14 pathway : XIST promotes ALI via miR-132-3p/MAPK14 axis.
    Li C; Liu JH; Su J; Lin WJ; Zhao JQ; Zhang ZH; Wu Q
    Mol Cell Biochem; 2021 Dec; 476(12):4217-4229. PubMed ID: 34346000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Effect of Dexmedetomidine on Acute Lung Injury via the Upregulation of Tumour Necrosis Factor-α-Induced Protein-8-like 2 in Septic Mice.
    Kong Q; Wu X; Qiu Z; Huang Q; Xia Z; Song X
    Inflammation; 2020 Jun; 43(3):833-846. PubMed ID: 31927655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-124 alleviates the lung injury in mice with septic shock through inhibiting the activation of the MAPK signaling pathway by downregulating MAPK14.
    Pan W; Wei N; Xu W; Wang G; Gong F; Li N
    Int Immunopharmacol; 2019 Nov; 76():105835. PubMed ID: 31476692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-139-5p protects septic mice with acute lung injury by inhibiting Toll-like receptor 4/Myeloid differentiation factor 88/Nuclear factor-&mac_kgr;B signaling pathway.
    Zhang X; Liu X; Chang R; Li Y
    Clinics (Sao Paulo); 2021; 76():e2484. PubMed ID: 33681946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14.
    Ji Q; Wang X; Cai J; Du X; Sun H; Zhang N
    Curr Neurovasc Res; 2019; 16(5):473-480. PubMed ID: 31713484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of miR-146b-3p protects septic mice with acute respiratory distress syndrome by inhibiting PI3K/AKT signaling pathway.
    Liu Y; Zhu JQ; Jin XH; Dong MP; Zheng JF
    J Bioenerg Biomembr; 2020 Aug; 52(4):229-236. PubMed ID: 32488541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine protects against acute lung injury in mice via the DUSP1/MAPK/NF-κB axis by inhibiting miR-152-3p.
    Han J; Liu X; Wang L
    Pulm Pharmacol Ther; 2022 May; ():102131. PubMed ID: 35551994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-155 Alleviates Septic Lung Injury by Inducing Autophagy Via Inhibition of Transforming Growth Factor-β-Activated Binding Protein 2.
    Liu F; Nie C; Zhao N; Wang Y; Liu Y; Li Y; Zeng Z; Ding C; Shao Q; Qing C; Xia L; Peng Z; Qian K
    Shock; 2017 Jul; 48(1):61-68. PubMed ID: 28125526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine suppresses the progression of esophageal cancer via miR-143-3p/epidermal growth factor receptor pathway substrate 8 axis.
    Zhang P; He H; Bai Y; Liu W; Huang L
    Anticancer Drugs; 2020 Aug; 31(7):693-701. PubMed ID: 32701250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
    Liu J; Huang X; Hu S; He H; Meng Z
    Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pathway of Let-7a-1/2-3p and HMGB1 Mediated Dexmedetomidine Inhibiting Microglia Activation in Spinal Cord Ischemia-Reperfusion Injury Mice.
    Ha Sen Ta Na ; Nuo M; Meng QT; Xia ZY
    J Mol Neurosci; 2019 Sep; 69(1):106-114. PubMed ID: 31190218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.
    Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J
    Biomed Pharmacother; 2020 May; 125():110001. PubMed ID: 32070878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-144-3p enhances LPS induced septic acute lung injury in mice through downregulating Caveolin-2.
    Xu R; Shao Z; Cao Q
    Immunol Lett; 2021 Mar; 231():18-25. PubMed ID: 33418009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [To explore the preventive and therapeutic effects of Xuebijing injection on acute lung injury induced by cardiopulmonary bypass in rats by regulating the expression of microRNA-17-5p and its mechanism].
    Xu Z; Liu D; Li K; Li X; Song L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jul; 31(7):867-872. PubMed ID: 31441412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine inhibits cell malignancy in osteosarcoma cells via miR-520a-3p-YOD1 interactome.
    Yan R; Jin S; Liu H; Le C; Gao J; Cheng J; Chen L; Li N
    Biochem Biophys Res Commun; 2021 Mar; 543():56-64. PubMed ID: 33515913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of miR-103a-3p suppresses lipopolysaccharide-induced sepsis and liver injury by regulating FBXW7 expression.
    Zhou YP; Xia Q
    Cell Biol Int; 2020 Sep; 44(9):1798-1810. PubMed ID: 32369227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulating microRNA-138-5p enhances the protective role of dexmedetomidine on myocardial ischemia-reperfusion injury mice via down-regulating Ltb4r1.
    Chang Y; Xing L; Zhou W; Zhang W
    Cell Cycle; 2021 Feb; 20(4):445-458. PubMed ID: 33509010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-103a-3p Could Attenuate Sepsis-Induced Liver Injury by Targeting HMGB1.
    Chen L; Lu Q; Deng F; Peng S; Yuan J; Liu C; Du X
    Inflammation; 2020 Dec; 43(6):2075-2086. PubMed ID: 32556802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.